Walvax Biotechnology Co., Ltd. (300142.SZ)
CNY 10.47
(4.7%)
CNY 10.47
(4.7%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.03 Billion CNY | 3.9% |
| 2022 | 995.81 Million CNY | 13.99% |
| 2021 | 873.59 Million CNY | 80.66% |
| 2020 | 483.55 Million CNY | 54.47% |
| 2019 | 313.04 Million CNY | 32.49% |
| 2018 | 236.28 Million CNY | 12.17% |
| 2017 | 210.64 Million CNY | 35.86% |
| 2016 | 155.04 Million CNY | 7.23% |
| 2015 | 144.59 Million CNY | -7.12% |
| 2014 | 155.67 Million CNY | -57.73% |
| 2013 | 368.27 Million CNY | 87.22% |
| 2012 | 196.7 Million CNY | 204.68% |
| 2011 | 64.56 Million CNY | 74.63% |
| 2010 | 36.97 Million CNY | 59.19% |
| 2009 | 23.22 Million CNY | 24.83% |
| 2008 | 18.6 Million CNY | 91.03% |
| 2007 | 9.73 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 1 Billion CNY | -8.53% |
| 2024 Q3 | 908.62 Million CNY | -9.77% |
| 2024 Q1 | 1.1 Billion CNY | 6.41% |
| 2023 Q4 | 1.03 Billion CNY | -5.03% |
| 2023 Q1 | 1.08 Billion CNY | 8.55% |
| 2023 FY | 1.03 Billion CNY | 3.9% |
| 2023 Q2 | 1.14 Billion CNY | 5.65% |
| 2023 Q3 | 1.08 Billion CNY | -4.6% |
| 2022 FY | 995.81 Million CNY | 13.99% |
| 2022 Q1 | 918.63 Million CNY | 5.16% |
| 2022 Q2 | 935.76 Million CNY | 1.86% |
| 2022 Q3 | 964.22 Million CNY | 3.04% |
| 2022 Q4 | 995.81 Million CNY | 3.28% |
| 2021 Q2 | 625.89 Million CNY | 9.36% |
| 2021 FY | 873.59 Million CNY | 80.66% |
| 2021 Q1 | 572.34 Million CNY | 18.36% |
| 2021 Q4 | 873.59 Million CNY | 6.85% |
| 2021 Q3 | 817.58 Million CNY | 30.63% |
| 2020 FY | 483.55 Million CNY | 54.47% |
| 2020 Q4 | 483.55 Million CNY | 8.66% |
| 2020 Q3 | 445.03 Million CNY | 7.96% |
| 2020 Q1 | 395.1 Million CNY | 26.21% |
| 2020 Q2 | 412.23 Million CNY | 4.34% |
| 2019 Q2 | 268.31 Million CNY | -1.71% |
| 2019 Q1 | 272.97 Million CNY | 15.53% |
| 2019 FY | 313.04 Million CNY | 32.49% |
| 2019 Q3 | 293.1 Million CNY | 9.24% |
| 2019 Q4 | 313.04 Million CNY | 6.8% |
| 2018 Q4 | 236.28 Million CNY | -3.01% |
| 2018 FY | 236.28 Million CNY | 12.17% |
| 2018 Q3 | 243.62 Million CNY | 16.61% |
| 2018 Q2 | 208.91 Million CNY | -7.22% |
| 2018 Q1 | 225.18 Million CNY | 6.9% |
| 2017 Q1 | 158.44 Million CNY | 2.19% |
| 2017 FY | 210.64 Million CNY | 35.86% |
| 2017 Q4 | 210.64 Million CNY | -2.98% |
| 2017 Q3 | 217.11 Million CNY | 9.84% |
| 2017 Q2 | 197.66 Million CNY | 24.75% |
| 2016 Q2 | 128 Million CNY | -24.68% |
| 2016 Q1 | 169.94 Million CNY | 17.53% |
| 2016 FY | 155.04 Million CNY | 7.23% |
| 2016 Q4 | 155.04 Million CNY | 8.35% |
| 2016 Q3 | 143.09 Million CNY | 11.79% |
| 2015 FY | 144.59 Million CNY | -7.12% |
| 2015 Q3 | 152.09 Million CNY | -12.57% |
| 2015 Q2 | 173.96 Million CNY | 3.47% |
| 2015 Q4 | 144.59 Million CNY | -4.93% |
| 2015 Q1 | 168.13 Million CNY | 8.0% |
| 2014 Q1 | 381.3 Million CNY | 3.54% |
| 2014 Q4 | 155.67 Million CNY | -60.82% |
| 2014 FY | 155.67 Million CNY | -57.73% |
| 2014 Q2 | 379.85 Million CNY | -0.38% |
| 2014 Q3 | 397.35 Million CNY | 4.61% |
| 2013 FY | 368.27 Million CNY | 87.22% |
| 2013 Q4 | 368.27 Million CNY | 5.99% |
| 2013 Q3 | 347.47 Million CNY | 39.71% |
| 2013 Q2 | 248.7 Million CNY | 14.62% |
| 2013 Q1 | 216.97 Million CNY | 10.3% |
| 2012 Q3 | 56.99 Million CNY | -0.99% |
| 2012 FY | 196.7 Million CNY | 204.68% |
| 2012 Q4 | 196.7 Million CNY | 245.12% |
| 2012 Q1 | 71.65 Million CNY | 10.98% |
| 2012 Q2 | 57.56 Million CNY | -19.66% |
| 2011 Q3 | 65.85 Million CNY | 4.23% |
| 2011 Q2 | 63.18 Million CNY | 1.64% |
| 2011 Q1 | 62.16 Million CNY | 68.14% |
| 2011 Q4 | 64.56 Million CNY | -1.96% |
| 2011 FY | 64.56 Million CNY | 74.63% |
| 2010 Q2 | 36.51 Million CNY | 0.0% |
| 2010 Q4 | 36.97 Million CNY | -4.67% |
| 2010 FY | 36.97 Million CNY | 59.19% |
| 2010 Q3 | 38.78 Million CNY | 6.2% |
| 2009 FY | 23.22 Million CNY | 24.83% |
| 2008 FY | 18.6 Million CNY | 91.03% |
| 2007 FY | 9.73 Million CNY | 0.0% |